Leishmania mexicana
Experimental TherapeuticsActivity of Chitosan and Its Derivatives against Leishmania major and Leishmania mexicana In VitroThere is an urgent need for safe, efficacious, affordable, and field-adapted drugs for the treatment of cutaneous leishmaniasis, which newly affects around 1.5 million people worldwide annually. Chitosan, a biodegradable cationic polysaccharide, has previously been reported to have antimicrobial, antileishmanial, and immunostimulatory activities.
- Experimental TherapeuticsEfficacy of Paromomycin-Chloroquine Combination Therapy in Experimental Cutaneous Leishmaniasis
- Mechanisms of Action: Physiological EffectsPerifosine Mechanisms of Action in Leishmania Species
- Mechanisms of Action: Physiological EffectsAmiodarone Destabilizes Intracellular Ca2+ Homeostasis and Biosynthesis of Sterols in Leishmania mexicana
- Experimental TherapeuticsAntileishmanial Activity of 1,3,4-Thiadiazolium-2-Aminide in Mice Infected with Leishmania amazonensis
- SusceptibilityActivity of Hydroxyurea against Leishmania mexicana